Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated. Their findings, published in the Proceedings of the National Academy of Sciences, suggest a potential new way to restore immune responsiveness and reduce mortality risk after severe infections.
Medical Xpress – latest medical and health news stories
